Skip to main content
Clinical Trials/NL-OMON28779
NL-OMON28779
Recruiting
N/A

Permanent left ventricular septal pacing versus right ventricular pacing in patients with atrioventricular conduction disorders: a randomized trial: LEAP trial

Maastricht University0 sites470 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Maastricht University
Enrollment
470
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \> 18y
  • Life expectancy with good functional status of \> 1y
  • Class I or IIa pacemaker indication due to an atrioventricular conduction disorder
  • oAcquired 3rd or 2nd degree AVB
  • oAtrial arrhythmia with slow ventricular conduction
  • Expected ventricular pacing percentage \> 20%
  • LVEF \>35%
  • Signed and dated informed consent form

Exclusion Criteria

  • Heart failure NYHA class III\-IV
  • Class I indication for CRT
  • Class I indication for ICD
  • Previous implanted CIED (except for ILR)
  • Atrial arrhythmia with planned AV junction ablation
  • PCI or CABG \<30 days before enrollment
  • Valvular heart disease with indication for valve repair or replacement
  • Hypertrophic cardiomyopathy with interventricular septal thickness \> 2 cm
  • Renal insufficiency requiring hemodialysis
  • Active infectious disease or malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials